Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Efficacy and safety of the dual GIP and GLP-1 receptor agonist tirzepatide for weight loss: a meta-analysis of randomized controlled trials
Yasmin Mesquita, Izabela Pera Calvi, Isabela Reis Marques, et al.
International Journal of Obesity (2023) Vol. 47, Iss. 10, pp. 883-892
Closed Access | Times Cited: 30

Showing 1-25 of 30 citing articles:

Medications for Obesity
Kimberly A. Gudzune, Robert F. Kushner
JAMA (2024) Vol. 332, Iss. 7, pp. 571-571
Closed Access | Times Cited: 50
Efficacy and safety of tirzepatide, GLP‐1 receptor agonists, and other weight loss drugs in overweight and obesity: a network meta‐analysis
Xin‐Hui Pan, B.C. Tan, Yip Han Chin, et al.
Obesity (2024) Vol. 32, Iss. 5, pp. 840-856
Closed Access | Times Cited: 20
Sarcopenia and Diabetes: A Detrimental Liaison of Advancing Age
Giuseppe Lisco, Olga Disoteo, Anna De Tullio, et al.
Nutrients (2023) Vol. 16, Iss. 1, pp. 63-63
Open Access | Times Cited: 31
Gut microbes in metabolic disturbances. Promising role for therapeutic manipulations?
Piero Portincasa, Mohamad Khalil, Annarita Graziani, et al.
European Journal of Internal Medicine (2023) Vol. 119, pp. 13-30
Closed Access | Times Cited: 29
The Emerging Role of Glucagon-like Peptide-1 Receptor Agonists in the Management of Obesity-Related Heart Failure with Preserved Ejection Fraction: Benefits beyond What Scales Can Measure?
Paschalis Karakasis, Nikolaos Fragakis, Dimitrios Patoulias, et al.
Biomedicines (2024) Vol. 12, Iss. 9, pp. 2112-2112
Open Access | Times Cited: 14
An integrative framework to prioritize genes in more than 500 loci associated with body mass index
Daiane Hemerich, Victor Svenstrup, Virginia Diez Obrero, et al.
The American Journal of Human Genetics (2024) Vol. 111, Iss. 6, pp. 1035-1046
Open Access | Times Cited: 9
Efficacy and safety of tirzepatide versus placebo in overweight or obese adults without diabetes: a systematic review and meta-analysis of randomized controlled trials
Ligang Liu, Hekai Shi, Merilyn Xie, et al.
International Journal of Clinical Pharmacy (2024) Vol. 46, Iss. 6, pp. 1268-1280
Open Access | Times Cited: 9
Weight Reduction with GLP-1 Agonists and Paths for Discontinuation While Maintaining Weight Loss
Allison B. Reiss, Shelly Gulkarov, Raymond Lau, et al.
Biomolecules (2025) Vol. 15, Iss. 3, pp. 408-408
Open Access | Times Cited: 1
Tirzepatide-related acute liver injury
Irrum Abdullah, Husam El-Ghousain, Meshaan Alenezi
European Journal of Case Reports in Internal Medicine (2024)
Open Access | Times Cited: 6
What Is Food Noise? A Conceptual Model of Food Cue Reactivity
Daisuke Hayashi Neto, Caitlyn G. Edwards, Jennifer A. Emond, et al.
Nutrients (2023) Vol. 15, Iss. 22, pp. 4809-4809
Open Access | Times Cited: 13
Mitigating Increased Cardiovascular Risk in Patients with Obstructive Sleep Apnea Using GLP-1 Receptor Agonists and SGLT2 Inhibitors: Hype or Hope?
Paschalis Karakasis, Μarios Sagris, Dimitrios Patoulias, et al.
Biomedicines (2024) Vol. 12, Iss. 11, pp. 2503-2503
Open Access | Times Cited: 5
Dopamine in the Regulation of Glucose Homeostasis, Pathogenesis of Type 2 Diabetes, and Chronic Conditions of Impaired Dopamine Activity/Metabolism: Implication for Pathophysiological and Therapeutic Purposes
Giuseppe Lisco, Anna De Tullio, Michele Iovino, et al.
Biomedicines (2023) Vol. 11, Iss. 11, pp. 2993-2993
Open Access | Times Cited: 11
Single and Combined Impact of Semaglutide, Tirzepatide, and Metformin on β-Cell Maintenance and Function Under High-Glucose–High-Lipid Conditions: A Comparative Study
Esmaeel Ghasemi Gojani, Bo Wang, Dongping Li, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 1, pp. 421-421
Open Access
Impact of Digital Engagement on Weight Loss Outcomes in Obesity Management: A Retrospective Service Evaluation of GLP-1 and Dual GLP-1/GIP Receptor Agonist Therapy in the United Kingdom (Preprint)
Hans Johnson, David Huang, Vivian Liu, et al.
Journal of Medical Internet Research (2025) Vol. 27, pp. e69466-e69466
Open Access
Role of Incretin Mimetics in the Management of Obesity
Shilpa Chugh Garcha, Sanjay Kalra
(2025), pp. 77-100
Closed Access
The Efficacy and Safety of Tirzepatide in Patients with Diabetes and/or Obesity: Systematic Review and Meta-Analysis of Randomized Clinical Trials
Ligang Liu, Hekai Shi, Merilyn Xie, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 5, pp. 668-668
Open Access
Efficacy and Safety of Cagrilintide Alone and in Combination with Semaglutide (Cagrisema) as Anti-Obesity Medications: A Systematic Review and Meta-Analysis
Deep Dutta, Lakshmi Nagendra, BG Harish, et al.
Indian Journal of Endocrinology and Metabolism (2024) Vol. 28, Iss. 5, pp. 436-444
Open Access | Times Cited: 3
Efficacy and Safety of Tirzepatide for Weight Management in Non-Diabetic Obese Individuals: A Narrative Review
Mohammed Sallam, Johan Snygg, Sara El Ghandour, et al.
Obesities (2025) Vol. 5, Iss. 2, pp. 26-26
Open Access
Is Tirzepatide the New Game Changer in Type 2 Diabetes?
Giuseppe Lisco, Olga Disoteo, Vincenzo De Geronimo, et al.
Endocrines (2024) Vol. 5, Iss. 1, pp. 72-86
Open Access | Times Cited: 3
Glucagon-Like Peptide-1 Receptor Agonists During Electroconvulsive Therapy
Randall Espinoza, Zarah Antongiorgi
Journal of Ect (2024) Vol. 40, Iss. 3, pp. 207-212
Closed Access | Times Cited: 2
Efficacy and safety of tirzepatide in overweight or obese adults without diabetes: systematic review and meta-analysis of randomized controlled trials
Ligang Liu, Milap C. Nahata, Hekai Shi, et al.
Research Square (Research Square) (2024)
Open Access | Times Cited: 2
Pasireotide-induced hyperglycemia in Cushing’s disease and Acromegaly: A clinical perspective and algorithms proposal
Przemysław Witek, Marek Bolanowski, Adam Krętowski, et al.
Frontiers in Endocrinology (2024) Vol. 15
Open Access | Times Cited: 1
Efficacy and safety of different doses of tirzepatide in patients with type 2 diabetes mellitus: a systematic review and network meta-analysis
Junxia Zhu, Yingjie Huang, Yang Luo, et al.
Research Square (Research Square) (2024)
Open Access
Tirzepatide cardiovascular benefits and adverse events assessment: a Bayesian network meta-analysis
xuyang gong, panpan cheng, yahui han, et al.
Research Square (Research Square) (2024)
Open Access
The KgA1c Paradox: Widening the spectrum
Sanjay Kalra, Suneet Verma, Nitin Kapoor
Journal of the Pakistan Medical Association (2024) Vol. 74, Iss. 7, pp. 1378-1379
Open Access
Page 1 - Next Page

Scroll to top